SkyePharma Plc, a specialist in drug delivery systems, has appointed Pierre Delavaud as executive vice president, sales & business development, at the British company's main research and development facilities in Muttenz, Switzerland.
Previously, Dr Delavaud was in charge of sales and business development for softgel capsules at the Catalent group.
Copyright 2011 Evernow Publishing Ltd